Merck & Company
Weekly Stock Prices Chart
This stock price chart for Merck & Company, symbol MRK, New York Stock Exchange is updated
weekly. TradingCharts.com offers over 30 thousand free stock price charts and stock market quotes.
[Add symbol to "MyMenu"]
Daily and Monthly charts are also available for Merck & Company.
Most Recent HeadlinesBIZ: Mar 28th, 2024, 06:45Length: 68445 European Commission Approves Merck's KEYTRUDA(R) (pembrolizumab) Plus Chemotherapy as Neoadjuvant Treatment, Then Continued as Monotherapy as Adjuvant Treatment, for Resectable Non-Small Cell Lung Cancer (NSCLC) at High Risk of Recurrence in Adults
BIZ: Mar 26th, 2024, 18:21Length: 15762 FDA Approves Merck's WINREVAIR(TM) (sotatercept-csrk), a First-in-Class Treatment for Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1)
BIZ: Mar 21st, 2024, 06:45Length: 83576 Merck Provides Update on Phase 3 KEYLYNK-006 Trial Evaluating KEYTRUDA(R) (pembrolizumab) Plus Maintenance LYNPARZA(R) (olaparib) for Certain Patients With Metastatic Nonsquamous Non-Small Cell Lung Cancer
MNV: Mar 20th, 2024, 10:13Length: 1073 Dow Movers: CAT, CSCO
BIZ: Mar 19th, 2024, 09:00Length: 16666 Merck Announces Positive Data on V116, an Investigational, 21-Valent Pneumococcal Conjugate Vaccine Specifically Designed for Adults, Demonstrated Immune Responses in Adults
BIZ: Mar 15th, 2024, 06:45Length: 67853 Merck's KEYTRUDA(R) (pembrolizumab) Plus Chemoradiotherapy (CRT) Significantly Improved Overall Survival (OS) Versus CRT Alone in Patients With Newly Diagnosed High-Risk Locally Advanced Cervical Cancer
|